NASDAQ · ANIX
Anixa Biosciences, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarThe next earnings date for ANIX has not been announced yet.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Oct 2026 | $-0.08 | $-0.08 | $-0.08 | 1 |
| Jan 2027 | $-0.08 | $-0.08 | $-0.08 | 1 |
| Apr 2027 | $-0.08 | $-0.08 | $-0.08 | 1 |
| Jul 2027 | $-0.08 | $-0.08 | $-0.08 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
BNK Invest · RTTNews · Zacks- BNK Invest · Oct 23, 1:48 PM EDTFriday 10/23 Insider Buying Report: NVA, ANIXAs the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy — they expect to make money. So let's look at two noteworthy recent insider buys. On Monday, Nova Minerals' Chief Executive Officer, Christopher Gerteisen, made a $2
- RTTNews · Oct 5, 10:02 AM EDTAnixa Biosciences Reports Stable Disease In Ovarian Cancer CAR-T Trial(RTTNews) – Anixa Biosciences, Inc. (ANIX) on Monday announced that the first patient in the current dose cohort of its Phase 1 clinical trial evaluating FSHR-targeted CAR-T therapy for recurrent ovarian cancer showed stable disease 90 days after treatment.
- RTTNews · Oct 1, 12:13 PM EDTAnixa Treats Second Patient At Highest Dose In Ovarian Cancer CAR-T Study(RTTNews) – Thursday, Anixa Biosciences (ANIX) announced that the second patient has been treated in the fifth cohort of its Phase 1 trial evaluating FSHR-targeted CAR-T therapy in patients with recurrent ovarian cancer.
- BNK Invest · Sep 25, 1:41 PM EDTFriday 9/25 Insider Buying Report: ANIX, BPREBargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is that they expect to make money. Today we
- RTTNews · Sep 21, 10:20 AM EDTAnixa Secures Australia Patent Covering Breast Cancer Vaccine Through 2040(RTTNews) – Anixa Biosciences, Inc. (ANIX), a clinical-stage biotechnology company announced that IP Australia has issued Patent Number 2020221280 related to Anixa's breast cancer vaccine technology, exclusively licensed from Cleveland Clinic.
- RTTNews · Sep 16, 10:33 AM EDTAnixa Biosciences Appoints UPenn's Dr. Carmen Guerra To Cancer Advisory Board(RTTNews) – Anixa Biosciences, Inc. (ANIX), a clinical-stage biotechnology company focused on cancer treatment and prevention, announced the appointment of Carmen Guerra, M.D., M.S.C.E., F.A.C.P., to its Cancer Business Advisory Board.
- RTTNews · Sep 8, 12:11 AM EDTISpecimen In Focus, Genelux Nears Phase 3 Ovarian Cancer Data, Biofrontera Awaits FDA Decision(RTTNews) – The biotech and pharma stocks to watch on Tuesday include iSpecimen, which gained more than 37% in overnight trading on Monday despite no specific news; Genelux, with a key clinical catalyst for its lead candidate Olvi-Vec expected in the coming months; Anixa Bioscien
- Zacks · Jul 22, 12:00 PM EDTAnixa Biosciences (ANIX) Upgraded to Strong Buy: Here's What You Should KnowAnixa Biosciences (ANIX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
- Zacks · Jul 22, 9:40 AM EDTAre Medical Stocks Lagging Allarity Therapeutics, Inc. (ALLR) This Year?Here is how Allarity Therapeutics, Inc. (ALLR) and ANIXA BIOSCIENCES INC (ANIX) have performed compared to their sector so far this year.
- Zacks · Jul 22, 7:15 AM EDTNew Strong Buy Stocks for July 22ndHTLD, YEXT, ANIX, WVE and LCNB have been added to the Zacks Rank #1 (Strong Buy) List on July 22, 2026.
- RTTNews · Jul 14, 11:25 AM EDTAnixa Gains Patent Protection In Australia For Breast Cancer Vaccine Technology(RTTNews) – Anixa Biosciences Inc. (ANIX), a biotechnology company, on Tuesday reported the acceptance of a patent by IP Australia for the company's proprietary breast cancer vaccine technology.
- RTTNews · Jun 29, 9:39 AM EDTAnixa Biosciences Wins South Korean Patent For Breast Cancer Vaccine(RTTNews) – Anixa Biosciences, Inc. (ANIX) on Monday said South Korea's Ministry of Intellectual Property has granted a patent covering its breast cancer vaccine technology, expanding the company's intellectual property portfolio.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Anixa Biosciences, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.